oncology management

Research in Review

Pathways for Chronic Kidney Disease Diverse and Inconsistent

08/02/2016

JCP Editors

A scoping review published in Nephrology Dialysis Transplantation has found that clinical pathways for chronic kidney disease (CKD) are diverse in their design, content, and implementation. This information may...

...

08/02/2016

Journal of Clinical Pathways

Research in Review

Enhanced Recovery After Surgery Pathways Improve Hospital Efficiency and Outcomes for Cystectomy Patients

08/02/2016

JCP Editors

Enhanced recovery after surgery (ERAS) pathways after cystectomy can reduce patients’ length of stay and improve quality of care, according to a study published in European Urology. ERAS pathways in urologic care...

...

08/02/2016

Journal of Clinical Pathways

Research in Review

Expectant Management for Prostate Cancer Underutilized at Community Centers

07/15/2016

JCP Editors

A retrospective analysis of hospital trends has shown that the likelihood of receiving expectant management for low-risk prostate cancer was significantly lower in men evaluated at community centers compared with...

A...

07/15/2016

Journal of Clinical Pathways

Research in Review

Statin Use May Improve Survival in Patients With Lung Cancer

07/11/2016

JCP Editors

Statin use may be associated with improved survival among patients with stage IV non-small cell lung cancer (NSCLC), according to findings from a study published in the journal Lung. Prior studies have shown that...

Statin...

07/11/2016

Journal of Clinical Pathways

Research in Review

Myeloma Treatment Patterns Vary Among European Practices

07/11/2016

JCP Editors

  There is significant variation in how European practices treat patients with multiple myeloma, according to a cross-sectional study published in the British Journal of Haematology. For the study,...

...

07/11/2016

Journal of Clinical Pathways

Research in Review

Genetic Testing for DCIS Unnecessary, Costing the US Millions

07/05/2016

JCP Editors

Automatically testing all core needle biopsy specimens showing ductal carcinoma in situ (DCIS) for estrogen receptor (ER) and progesterone receptor (PR) is highly expensive and may not be needed, according to a study...

...

07/05/2016

Journal of Clinical Pathways

Research in Review

Breast Cancer Treatment May Lead to Functional Decline or Death in Elderly Patients

07/01/2016

JCP Editors

Many older women diagnosed with nonmetastatic breast cancer may experience functional decline or death within 12 months of breast cancer treatment initiation, but the Vulnerable Elders Survey (VES-12) may help to...

Many...

07/01/2016

Journal of Clinical Pathways

Interview

Reducing Waste in Oncology Drug Use

06/20/2016

  According to a recent report, prescription drug costs rose by more than 12% in 2014 and are expected to continue to rise by more than 7% through 2018.1 In addition, a study of the out-of-pocket costs...

...

06/20/2016

Journal of Clinical Pathways

Web Application Improves Survival and Follow-up for Patients With Lung Cancer

06/10/2016

JCP Editors

Using a web-based application to guide follow-up for patients with advanced lung cancer after they have received initial therapy may improve survival, according to a study presented at the 2016 American Society of...

Using...

06/10/2016

Journal of Clinical Pathways

Prostate Cancer Treatment Associated With More Adverse Events

06/10/2016

JCP Editors

Patients with metastatic castrate resistant prostate cancer treated with enzalutamide (ENZ) may be more likely to experience central nervous system adverse events and fatigue than those who receive a combination of...

...

06/10/2016

Journal of Clinical Pathways